Financhill
Back

Cocrystal Pharma Quote, Financials, Valuation and Earnings

Cocrystal Pharma Price Quote

$1.77
+0.01 (+0.57%)
(Updated: November 13, 2024 at 5:55 PM ET)

Cocrystal Pharma Key Stats

Buy
58
Cocrystal Pharma (COCP) is a Buy

Day range:
$1.74 - $1.80
52-week range:
$1.33 - $3.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.90
P/B ratio:
1.03%

Volume:
11.6K
Avg. volume:
19.6K
1-year change:
-7.37%
Market cap:
$17.9M
Revenue:
$0
EPS:
$-1.77

How Much Does Cocrystal Pharma Make?

Data Unavailable

Is Cocrystal Pharma Growing As A Company?

Data Unavailable

Cocrystal Pharma Stock Price Performance

  • Did Cocrystal Pharma Stock Go Up Last Month?
    Cocrystal Pharma share price went up by 0% last month
  • Did COCP's Share Price Rise Over The Last Year?
    COCP share price fell by -7.37% over the past 1 year

What Is Cocrystal Pharma 52-Week High & Low?

Cocrystal Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cocrystal Pharma?

  • How Much Debt Does Cocrystal Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cocrystal Pharma Have?
    Cash and short term investments quarterly total is $18.1M
  • What Is Cocrystal Pharma’s Book Value Per Share?
    Book value per share is 1.71

Is Cocrystal Pharma Cash Flow Positive?

  • What Is COCP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.2M
  • What Is Cocrystal Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Cocrystal Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$67K

Cocrystal Pharma Return On Invested Capital

Data Unavailable

Cocrystal Pharma Earnings Date & Stock Price

Cocrystal Pharma Competitors

  • Who Are Cocrystal Pharma's Competitors?
    Below is a list of companies who compete with Cocrystal Pharma or are related in some way:
    • Cara Therapeutics Inc (CARA)
    • Perspective Therapeutics Inc (CATX)
    • Jaguar Health Inc (JAGX)
    • Oragenics Inc (OGEN)
    • Alaunos Therapeutics Inc (TCRT)

Cocrystal Pharma Dividend Yield

Cocrystal Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 30.36%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Upside from Last Price: 354.55%

Major Shareholders

  • How many COCP shares are owned by institutional investors?
    1M COCP shares are owned by institutional investors
  • How many COCP shares are owned by insiders?
    0 COCP shares are owned by insiders